These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 14061106)

  • 21. Relationship between duodenal calcium-binding protein, parathyroid activity and various parameters of mineral metabolism in the rachitic and vitamin D-treated chick.
    Bar A; Hurwitz S; Cohen I
    Comp Biochem Physiol A Comp Physiol; 1972 Nov; 43(3):519-26. PubMed ID: 4144132
    [No Abstract]   [Full Text] [Related]  

  • 22. A brief history of rickets.
    Friedman A
    Pediatr Nephrol; 2020 Oct; 35(10):1835-1841. PubMed ID: 31654223
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RACHITOGENIC ACTIVITY OF SOYBEAN FRACTIONS.
    Carlson CW; Saxena HC; Jensen LS; Mcginnis J
    J Nutr; 1964 Apr; 82(4):507-11. PubMed ID: 14151141
    [No Abstract]   [Full Text] [Related]  

  • 24. EXTERNAL CALCIUM AND PHOSPHORUS BALANCES. A COMPARATIVE STUDY OF RENAL DISEASE AND THE CELIAC SYNDROME.
    STRICKLER GB; BURKE EC
    Am J Dis Child; 1963 Aug; 106():154-60. PubMed ID: 14056811
    [No Abstract]   [Full Text] [Related]  

  • 25. Disordered mineral metabolism and vascular calcification in nondialyzed chronic kidney disease patients.
    Mehrotra R
    J Ren Nutr; 2006 Apr; 16(2):100-18. PubMed ID: 16567266
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [K/DOQI clinical practice guidelines for bone metabolism and disease in CKD].
    Sakaguchi T; Akizawa T
    Clin Calcium; 2004 Sep; 14(9):9-14. PubMed ID: 15577103
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endocrine and bone consequences of cyclic nutritional changes in the calcium, phosphate and vitamin D status in the rat: an in vivo depletion-repletion-redepletion study.
    Mailhot G; Petit JL; Dion N; Deschênes C; Ste-Marie LG; Gascon-Barré M
    Bone; 2007 Sep; 41(3):422-36. PubMed ID: 17617234
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical practice guidelines for bone metabolism and disease in chronic kidney disease: an overview.
    Bailie GR; Massry SG;
    Pharmacotherapy; 2005 Dec; 25(12):1687-707. PubMed ID: 16305288
    [TBL] [Abstract][Full Text] [Related]  

  • 29. INFLUENCE OF PARATHYROID ACTIVITY ON ION EXCHANGE IN VARIOUS TISSUES.
    ELIEL LP; CHANES R; HAWRYLKO J
    Trans Am Clin Climatol Assoc; 1962; 74():130-8. PubMed ID: 14044603
    [No Abstract]   [Full Text] [Related]  

  • 30. [Rickets as a syndrome of metabolic disorders].
    Szczepski O; Bittner K; Maciejewski J
    Pol Tyg Lek; 1970 Dec; 25(51):1999-2002. PubMed ID: 4927211
    [No Abstract]   [Full Text] [Related]  

  • 31. [The effect of sterols and steroids on the body calcium fractions].
    Harnapp GO
    Z Arztl Fortbild (Jena); 1969 Jun; 63(11):612-21. PubMed ID: 5806768
    [No Abstract]   [Full Text] [Related]  

  • 32. Recent advances in the genetics of disorders of calcium homeostasis.
    Root AW
    Adv Pediatr; 1996; 43():77-125. PubMed ID: 8794175
    [No Abstract]   [Full Text] [Related]  

  • 33. [Physiological, pharmacological, and toxicological aspects of bone metabolism].
    Schmid A
    Berl Munch Tierarztl Wochenschr; 1968 Jul; 81(14):281-5. PubMed ID: 4234478
    [No Abstract]   [Full Text] [Related]  

  • 34. Evaluation of bone and mineral disorders.
    Ardeshirpour L; Cole DE; Carpenter TO
    Pediatr Endocrinol Rev; 2007 Oct; 5 Suppl 1():584-98. PubMed ID: 18167468
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of lowering dialysate calcium concentration on mineral metabolism and parathyroid hormone secretion: a multicentric study.
    Lezaic V; Pejanovic S; Kostic S; Pljesa S; Dimkovic N; Komadina L; Jovanovic D; Marinkovic J; Djukanovic L
    Ther Apher Dial; 2007 Apr; 11(2):121-30. PubMed ID: 17381533
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Calcium metabolism and anti-aging of bone].
    Hosoi T
    Clin Calcium; 2008 Jul; 18(7):918-22. PubMed ID: 18591742
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of calcium metabolism disorders in infants].
    RETT A
    Wien Med Wochenschr; 1955 Apr; 105(13):274-5. PubMed ID: 14374516
    [No Abstract]   [Full Text] [Related]  

  • 38. Mineral metabolism disturbances in patients with chronic kidney disease.
    Kestenbaum B; Belozeroff V
    Eur J Clin Invest; 2007 Aug; 37(8):607-22. PubMed ID: 17635571
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Linear growth in relation to the circulating concentrations of insulin-like growth factor I, parathyroid hormone, and 25-hydroxy vitamin D in children with nutritional rickets before and after treatment: endocrine adaptation to vitamin D deficiency.
    Soliman AT; Al Khalaf F; Alhemaidi N; Al Ali M; Al Zyoud M; Yakoot K
    Metabolism; 2008 Jan; 57(1):95-102. PubMed ID: 18078865
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sevelamer controls parathyroid hormone-induced bone disease as efficiently as calcium carbonate without increasing serum calcium levels during therapy with active vitamin D sterols.
    Salusky IB; Goodman WG; Sahney S; Gales B; Perilloux A; Wang HJ; Elashoff RM; Jüppner H
    J Am Soc Nephrol; 2005 Aug; 16(8):2501-8. PubMed ID: 15944337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.